Project Grant R01AG097735
- The National Institute on Aging awarded the University of North Carolina at Chapel Hill $1,628,644 on September 15, 2025, under the Aging Research program (CFDA 93.866) to conduct GOC ADVANCE, a cluster randomized controlled trial testing a communication intervention to improve shared decision-making about goals of care for family decision-makers of nursing home residents with late-stage Alzheimer's disease and related dementias. The trial enrolls 300 participants (150 dyads per study arm)...
- The National Institute on Aging awarded the Regents of the University of Michigan $758,442 on September 1, 2026, under the Aging Research program (CFDA 93.866) to develop and test two pragmatic interventions aimed at increasing brain donation among older adults at risk for Alzheimer's disease and related dementias. The project, "The Brain Gifting Counseling Program: A Novel Peer-Professional Intervention to Enhance Brain Donation Among Older Adults at Risk for Alzheimer's Disease and...
- The National Institute of Neurological Disorders and Stroke awarded $233,280 to the Regents of the University of Michigan on March 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to identify and address factors that delay acute stroke treatment delivery via telestroke. The project, titled "Understanding and Improving Acute Telestroke Care" and led by Principal Investigator Brian Stamm, MD, MSC, will characterize...
- The National Institute on Aging awarded Yale University $182,018 on August 15, 2026, through the Aging Research program (CFDA 93.866) to support Dr. Snigdha Jain's career development as an independent investigator leading the development and testing of interventions that improve shared decision-making about critical care interventions for older adults with Alzheimer's disease and Alzheimer's disease-related dementias. The award funds three research aims addressing invasive mechanical ventilation...
- The National Institute on Aging awarded the Regents of the University of Michigan $844,638 on September 15, 2025, under the Aging Research program (CFDA 93.866) to implement and test a pharmacist-led care transition program for rural older adults with dementia. The project adapts the Region VII Area Agency on Aging Community Care Transition Initiative (CCTI) for older adults with Alzheimer's disease and related dementias (ADRD) and their care partners. Rural older adults with ADRD commonly...
- The National Institute on Aging awarded Rochester Institute of Technology $125,650 on September 15, 2026, under the Aging Research program (CFDA 93.866) to develop and evaluate a smartphone-based digital coaching system for fall prevention in stroke survivors. The project delivers three core products: a prototype digital coaching application providing personalized reminders, exercise prompts, and safety guidance co-designed with stroke survivors, caregivers, and physical therapists; pilot...
- The National Institute on Aging awarded the University of Rochester $188,445 on August 5, 2026, under the Aging Research program (CFDA 93.866) to conduct a randomized controlled trial evaluating dyadic life review therapy for distressed caregivers of older patients with Alzheimer's disease and related dementias and advanced cancer. The study will enroll 60 dyads of patients aged 65 and older with clinical impressions of AD/ADRD (including mild cognitive impairment) and stage III or IV cancer,...
- The National Institute on Aging awarded Tufts Medical Center Parent, Inc. (doing business as Tufts Medical Center) a $8.296 million Cooperative Agreement on July 1, 2026, under the Aging Research program (CFDA 93.866) to develop and test an advance care planning educator video program for older adults and those with Alzheimer's disease and related dementias. The program addresses a documented gap between the medical care older Americans want when facing serious illness and the care they receive,...
- The National Institute on Aging awarded $453,932 to the University of Pittsburgh on February 1, 2026, under the Aging Research program (CFDA 93.866) to develop and pilot-test a narrative video game designed to improve advance care planning by persons living with dementia. The project addresses two cognitive biases that impair advance care planning decisions: affective forecasting bias (individuals' inaccuracy in predicting how they will feel in future health states) and representativeness bias...
- The National Institute on Aging awarded The University of Chicago $597,239 on September 1, 2026, under the Aging Research program (CFDA 93.866) to support investigation of inpatient rehabilitation facility (IRF) utilization and outcomes for older adult patients with and without Alzheimer's disease or other dementias (ADRD). The research examines comparative value and appropriateness of care delivery across post-acute care settings, specifically comparing higher-cost IRF care—which provides acute...
The National Institute on Aging awarded the Regents of the University of Michigan $763,105 on September 1, 2026, under the Aging Research program (CFDA 93.866) to test the efficacy of the I-DECIDE intervention among recent stroke survivors and their advance care planning partners. I-DECIDE combines PREPARE, an evidence-based advance care planning intervention delivered at home, with a robust engagement program designed in partnership with a stroke advisory board. The engagement program includes an introductory video featuring testimonials from stroke survivors and their care partners discussing advance care planning, and an AI-driven motivational interviewing-based text messaging tool. The study will assess advance care planning completion through a multicenter, prospective, randomized open-, blinded-endpoint attention-controlled trial with outcomes measured at six months, evaluating self-reported completion of four critical elements of advance care planning including signing official papers naming a medical decision-maker. The trial addresses a gap in evidence-based advance care planning for stroke survivors, who face elevated risk of morbidity, mortality, recurrent stroke, Alzheimer disease, and Alzheimer disease-related dementia yet remain largely unprepared for medical decision-making. PREPARE has demonstrated efficacy in general populations but has not been tested among recent stroke survivors in real-world delivery settings outside supervised research environments. Work is performed at the University of Michigan, Ann Arbor, Michigan. The award period runs through August 31, 2031.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $763.1k | 9/1/26 |